Consolidated Schedule of Investments - USD ($)		Dec. 31, 2023		Dec. 31, 2022
Schedule of Investments [Line Items]
Amortized Cost		$ 45,998,823		$ 54,011,971
Fair Value		49,413,286		53,293,715
Investment, Identifier [Axis]: Asset-Backed Securitie
Schedule of Investments [Line Items]
Fair Value	[1],[2]	84		7,036
Investment, Identifier [Axis]: Asset-Backed Securities | Financials
Schedule of Investments [Line Items]
Fair Value	[1],[2]			7,036
Investment, Identifier [Axis]: Asset-Backed Securities | Financials | Grayson Investor Corp.
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[3],[6],[7]	800	[4],[5],[8]	800	[9],[10],[11]
Amortized Cost	[1],[2],[3],[6],[7],[12]	218,666	[4],[5],[8]	218,666	[9],[10],[11]
Fair Value	[1],[2],[3],[6],[7]	84	[4],[5],[8]	7,023	[9],[10],[11]
Investment, Identifier [Axis]: Asset-Backed Securities | Financials | PAMCO CLO 1997-1A B
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[3],[6],[9],[10],[11],[13]			295,435
Amortized Cost	[1],[2],[3],[6],[9],[10],[11],[12],[13]			169,875
Fair Value	[1],[2],[3],[6],[9],[10],[11],[13]			13
Investment, Identifier [Axis]: Common Stocks
Schedule of Investments [Line Items]
Fair Value	[1],[2]	15,961,319		19,514,684
Investment, Identifier [Axis]: Common Stocks | Chemicals | MPM Holdings Inc.
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[12],[14]	17,000	[3],[4]	17,000
Fair Value	[1],[2],[14]	42,500	[3],[4]	42,500
Investment, Identifier [Axis]: Common Stocks | Energy | Quarternorth Energy Inc.
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[12]	1,563,928		981,428
Fair Value	[1],[2]	2,237,604		1,591,692
Investment, Identifier [Axis]: Common Stocks | Financials | American Banknote Corp.
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[3],[12],[14]	2,062,500	[4]	2,062,500	[9]
Fair Value	[1],[2],[3],[14]	3,536,250	[4]	1,732,500	[9]
Investment, Identifier [Axis]: Common Stocks | Real Estate
Schedule of Investments [Line Items]
Fair Value	[1],[2]	4,606,797		10,012,730
Investment, Identifier [Axis]: Common Stocks | Real Estate Investment Trust (REIT) | NexPoint Residential Trust Inc.
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[12]	701,237	[8],[15]	698,189	[11],[16]
Fair Value	[1],[2]	805,987	[8],[15]	1,018,779	[11],[16]
Investment, Identifier [Axis]: Common Stocks | Real Estate | IQHQ Inc.
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[3],[12]	1,500,000	[4]	1,500,000	[9]
Fair Value	[1],[2],[3]	2,533,000	[4]	2,359,000	[9]
Investment, Identifier [Axis]: Common Stocks | Real Estate | Nexpoint Real Estate Finance Inc.
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[12]	2,479,467	[15]	9,960,591	[16]
Fair Value	[1],[2]	2,073,797	[15]	7,653,730	[16]
Investment, Identifier [Axis]: Common Stocks | Service | Wayne Services Legacy Inc.
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[3],[9],[12],[14]			253,404
Fair Value	[1],[2],[3],[9],[14]			2,269
Investment, Identifier [Axis]: Common Stocks | Telecommunication Services | MidWave Wireless, Inc. (fka Terrestar Corp.)
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[3],[12],[14]	1,599,990	[4]	1,599,990	[9]
Fair Value	[1],[2],[3],[14]	4,732,181	[4]	5,114,214	[9]
Investment, Identifier [Axis]: Corporate Bonds
Schedule of Investments [Line Items]
Fair Value	[1],[2]	$ 727,523		$ 2,704,917
Investment, Identifier [Axis]: Corporate Bonds | Consumer Discretionary | Vista Outdoor, Inc. | 4.50% | 03/15/2029
Schedule of Investments [Line Items]
Base Rate Floor	[1],[2]	4.50%
Maturity Date	[1],[2]	Mar. 15, 2029
Principal Amount	[1],[2]	$ 500,000
Amortized Cost	[1],[2],[12]	482,645
Fair Value	[1],[2]	488,665
Investment, Identifier [Axis]: Corporate Bonds | Healthcare | Hadrian Merger Sub Inc. | 8.500% | 5/1/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[10]			8.50%
Maturity Date	[1],[2],[10]			May 01, 2026
Principal Amount	[1],[2],[10]			$ 2,728,000
Amortized Cost	[1],[2],[10],[12]			2,460,536
Fair Value	[1],[2],[10]			2,414,839
Investment, Identifier [Axis]: Corporate Bonds | Media/Telecommunications
Schedule of Investments [Line Items]
Fair Value	[1],[2]	$ 238,858		$ 290,078
Investment, Identifier [Axis]: Corporate Bonds | Media/Telecommunications | iHeartCommunications Inc. | 6.375% | 5/1/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[11]			6.375%
Maturity Date	[1],[2],[11]			May 01, 2026
Principal Amount	[1],[2],[11]			$ 116,808
Amortized Cost	[1],[2],[11],[12]			313,455
Fair Value	[1],[2],[11]			$ 107,648
Investment, Identifier [Axis]: Corporate Bonds | Media/Telecommunications | iHeartCommunications Inc. | 6.38% | 05/01/2026
Schedule of Investments [Line Items]
Base Rate Floor	[1],[2]	6.38%
Maturity Date	[1],[2]	May 01, 2026
Principal Amount	[1],[2],[8]	$ 116,808
Amortized Cost	[1],[2],[8],[12]	313,455
Fair Value	[1],[2],[8]	$ 99,711
Investment, Identifier [Axis]: Corporate Bonds | Media/Telecommunications | iHeartCommunications Inc. | 8.375% | 5/1/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[11]			8.375%
Maturity Date	[1],[2],[11]			May 01, 2027
Principal Amount	[1],[2],[11]			$ 214,073
Amortized Cost	[1],[2],[11],[12]			584,792
Fair Value	[1],[2],[11]			182,430
Investment, Identifier [Axis]: Corporate Bonds | Media/Telecommunications | iHeartCommunications Inc. | 8.38% | 05/01/2027
Schedule of Investments [Line Items]
Base Rate Floor	[1],[2]	8.38%
Maturity Date	[1],[2]	May 01, 2027
Principal Amount	[1],[2],[8]	$ 214,073
Amortized Cost	[1],[2],[8],[12]	584,792
Fair Value	[1],[2],[8]	139,147
Investment, Identifier [Axis]: LLC Interests
Schedule of Investments [Line Items]
Fair Value	[1],[2]	10,370,499		4,689,242
Investment, Identifier [Axis]: LLC Interests | Consumer Products | US Gaming LLC
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[3],[12],[14]	1,700,000	[4]	2,000,000	[9]
Fair Value	[1],[2],[3],[14]	3,016,752	[4]	3,088,750	[9]
Investment, Identifier [Axis]: LLC Interests | Real Estate
Schedule of Investments [Line Items]
Fair Value	[1],[2]	7,353,747		1,600,492
Investment, Identifier [Axis]: LLC Interests | Real Estate | NexPoint Capital REIT LLC
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[3],[12]	8,418,892	[4],[15]	1,215,000	[9],[16]
Fair Value	[1],[2],[3]	7,014,774	[4],[15]	1,176,024	[9],[16]
Investment, Identifier [Axis]: LLC Interests | Real Estate | SFR WLIF III LLC
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[3],[12]	371,111	[4],[15]	451,112	[9],[16]
Fair Value	[1],[2],[3]	338,973	[4],[15]	424,468	[9],[16]
Investment, Identifier [Axis]: Net Assets
Schedule of Investments [Line Items]
Fair Value	[1],[2]	49,809,526		53,694,167
Investment, Identifier [Axis]: Preferred Stocks
Schedule of Investments [Line Items]
Fair Value	[1],[2]	11,822,375		11,967,910
Investment, Identifier [Axis]: Preferred Stocks | Financials
Schedule of Investments [Line Items]
Fair Value	[1],[2]	1,186,250		1,440,625
Investment, Identifier [Axis]: Preferred Stocks | Financials | 777 Partners LLC | 10.00%
Schedule of Investments [Line Items]
Principal Amount	[1],[2]	750
Amortized Cost	[1],[2],[12]	750,000
Fair Value	[1],[2]	686,250
Investment, Identifier [Axis]: Preferred Stocks | Financials | 777 Partners LLC | 10.000 %
Schedule of Investments [Line Items]
Principal Amount	[1],[2]			750
Amortized Cost	[1],[2],[12]			750,000
Fair Value	[1],[2]			740,625
Investment, Identifier [Axis]: Preferred Stocks | Financials | United Fidelity Bank FSB | 7.00%
Schedule of Investments [Line Items]
Principal Amount	[1],[2]	1,000
Amortized Cost	[1],[2],[12]	1,000,000
Fair Value	[1],[2]	500,000
Investment, Identifier [Axis]: Preferred Stocks | Financials | United Fidelity Bank FSB | 7.000 %
Schedule of Investments [Line Items]
Principal Amount	[1],[2]			1,000
Amortized Cost	[1],[2],[12]			1,000,000
Fair Value	[1],[2]			700,000
Investment, Identifier [Axis]: Preferred Stocks | Healthcare
Schedule of Investments [Line Items]
Fair Value	[1],[2]	10,636,125		10,527,285
Investment, Identifier [Axis]: Preferred Stocks | Healthcare | Apnimed Inc. (Series C-2) | 8.00%
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[3],[4]	72,065
Amortized Cost	[1],[2],[3],[4],[12]	799,994
Fair Value	[1],[2],[3],[4]	928,197
Investment, Identifier [Axis]: Preferred Stocks | Healthcare | Apnimed Inc. (Series C-2) | 8.000 %
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[3],[9]			72,065
Amortized Cost	[1],[2],[3],[9],[12]			799,994
Fair Value	[1],[2],[3],[9]			799,994
Investment, Identifier [Axis]: Preferred Stocks | Healthcare | Apnimed Inc. | 8.00%
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[3],[4]	135,122
Amortized Cost	[1],[2],[3],[4],[12]	1,199,993
Fair Value	[1],[2],[3],[4]	1,644,435
Investment, Identifier [Axis]: Preferred Stocks | Healthcare | Apnimed Inc. | 8.000 %
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[3],[9]			135,122
Amortized Cost	[1],[2],[3],[9],[12]			1,199,993
Fair Value	[1],[2],[3],[9]			1,499,989
Investment, Identifier [Axis]: Preferred Stocks | Healthcare | Sapience Therapeutics Inc. (Series B Preferred Shares) | 8.00%
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[3],[4],[17]	1,863,468
Amortized Cost	[1],[2],[3],[4],[12],[17]	4,080,000
Fair Value	[1],[2],[3],[4],[17]	4,452,382
Investment, Identifier [Axis]: Preferred Stocks | Healthcare | Sapience Therapeutics Inc. (Series B Preferred Shares) | 8.000 %
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[3],[9]			1,619,048
Amortized Cost	[1],[2],[3],[9],[12]			4,080,000
Fair Value	[1],[2],[3],[9]			4,549,525
Investment, Identifier [Axis]: Preferred Stocks | Healthcare | Sapience Therapeutics Inc. (Series B-1 Preferred Shares)
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[3],[9]			1,111,111
Amortized Cost	[1],[2],[3],[9],[12]			4,000,000
Fair Value	[1],[2],[3],[9]			3,677,777
Investment, Identifier [Axis]: Preferred Stocks | Healthcare | Sapience Therapeutics Inc. (Series B-1 Preferred Shares) | 8.00%
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[3],[4],[17]	1,311,091
Amortized Cost	[1],[2],[3],[4],[12],[17]	4,000,000
Fair Value	[1],[2],[3],[4],[17]	3,611,111
Investment, Identifier [Axis]: Senior Secured Loans
Schedule of Investments [Line Items]
Fair Value	[1],[2]	$ 10,258,517	[18]	14,228,193	[19]
Investment, Identifier [Axis]: Senior Secured Loans | Bioplastics | PlantSwitch, Inc. Convertible Promissory Note (First Lien Term Loan) | 10% Fixed | 9/20/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[4],[18]	10.00%
Maturity Date	[1],[2],[3],[4],[18]	Sep. 20, 2026
Principal Amount	[1],[2],[3],[4],[18]	$ 2,000,000
Amortized Cost	[1],[2],[3],[4],[12],[18]	2,000,000
Fair Value	[1],[2],[3],[4],[18]	2,000,000
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare
Schedule of Investments [Line Items]
Fair Value	[1],[2]	$ 6,592,574	[18]	$ 13,158,950	[19]
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Auris Luxembourg III S.a.r.l. (First Lien Term Loan) | L + 375 | 4.93 % | 2/27/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[11],[19],[20]			375.00%
Base Rate Floor	[1],[2],[11],[19],[20]			4.93%
Maturity Date	[1],[2],[11],[19],[20]			Feb. 27, 2026
Principal Amount	[1],[2],[11],[19],[20]			$ 1,468,909
Amortized Cost	[1],[2],[11],[12],[19],[20]			1,465,131
Fair Value	[1],[2],[11],[19],[20]			$ 1,318,346
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Auris Luxembourg III S.a.r.l. (First Lien Term Loan) | SOFR + 375 | 5.37% | 2/27/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[8],[18],[21]	375.00%
Base Rate Floor	[1],[2],[8],[18],[21]	5.87%
Maturity Date	[1],[2],[8],[18],[21]	Feb. 27, 2026
Principal Amount	[1],[2],[8],[18],[21]	$ 1,453,650
Amortized Cost	[1],[2],[8],[12],[18],[21]	1,450,998
Fair Value	[1],[2],[8],[18],[21]	$ 1,438,750
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | CCS Medical Inc (First Lien Term Loan) | 14% Fixed |4/7/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[9],[19],[22]			14.00%
Maturity Date	[1],[2],[3],[9],[19],[22]			Apr. 07, 2026
Principal Amount	[1],[2],[3],[9],[19],[22]			$ 3,000,000
Amortized Cost	[1],[2],[3],[9],[12],[19],[22]			2,926,520
Fair Value	[1],[2],[3],[9],[19],[22]			$ 3,000,000
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | CCS Medical, Inc (First Lien Term Loan) | 11% Fixed | 4/7/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[4],[18]	11.00%
Maturity Date	[1],[2],[3],[4],[18]	Apr. 07, 2026
Principal Amount	[1],[2],[3],[4],[18]	$ 3,000,000
Amortized Cost	[1],[2],[3],[4],[12],[18]	2,945,554
Fair Value	[1],[2],[3],[4],[18]	$ 3,000,000
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | CNT Holdings I Corp (Second Lien Term Loan) | L + 675 | 3.74 % | 11/6/2028
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[19],[22]			675.00%
Base Rate Floor	[1],[2],[19],[22]			3.74%
Maturity Date	[1],[2],[19],[22]			Nov. 06, 2028
Principal Amount	[1],[2],[19],[22]			$ 1,500,000
Amortized Cost	[1],[2],[12],[19],[22]			1,494,084
Fair Value	[1],[2],[19],[22]			$ 1,422,503
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Carestream Health Inc. (First Lien Term Loan) | L + 675 | 12.18 % | 9/30/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[19],[22]			675.00%
Base Rate Floor	[1],[2],[19],[22]			12.18%
Maturity Date	[1],[2],[19],[22]			Sep. 30, 2027
Principal Amount	[1],[2],[19],[22]			$ 668,605
Amortized Cost	[1],[2],[12],[19],[22]			576,001
Fair Value	[1],[2],[19],[22]			$ 511,483
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Carestream Health, Inc. (First Lien Term Loan) | SOFR + 750 | 5.36% | 9/30/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[18],[23]	750.00%
Base Rate Floor	[1],[2],[18],[23]	5.36%
Maturity Date	[1],[2],[18],[23]	Sep. 30, 2027
Principal Amount	[1],[2],[18],[23]	$ 658,467
Amortized Cost	[1],[2],[12],[18],[23]	581,366
Fair Value	[1],[2],[18],[23]	$ 514,635
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Covenant Surgical Partners Inc. (First Lien Delayed Draw Term Loan) | 4% Fixed | 7/1/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[19]			4.00%
Maturity Date	[1],[2],[19]			Jul. 01, 2026
Principal Amount	[1],[2],[19]			$ 333,333
Amortized Cost	[1],[2],[12],[19]			333,817
Fair Value	[1],[2],[19]			$ 282,500
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Covenant Surgical Partners Inc. (First Lien Term Loan) | L + 400 | 4.41 % | 7/1/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[19],[24]			400.00%
Base Rate Floor	[1],[2],[19],[24]			4.41%
Maturity Date	[1],[2],[19],[24]			Jul. 01, 2026
Principal Amount	[1],[2],[19],[24]			$ 1,613,305
Amortized Cost	[1],[2],[12],[19],[24]			1,615,775
Fair Value	[1],[2],[19],[24]			$ 1,367,276
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Covenant Surgical Partners, Inc. (First Lien Delayed Draw Term Loan) | SOFR + 400 | 5.38% | 7/1/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[18],[23]	400.00%
Base Rate Floor	[1],[2],[18],[23]	5.38%
Maturity Date	[1],[2],[18],[23]	Jul. 01, 2026
Principal Amount	[1],[2],[18],[23]	$ 333,333
Amortized Cost	[1],[2],[12],[18],[23]	333,679
Fair Value	[1],[2],[18],[23]	$ 261,000
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Covenant Surgical Partners, Inc. (First Lien Term Loan) | SOFR + 400 | 5.38 % | 7/1/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[18],[23]	400.00%
Base Rate Floor	[1],[2],[18],[23]	5.38%
Maturity Date	[1],[2],[18],[23]	Jul. 01, 2026
Principal Amount	[1],[2],[18],[23]	$ 1,597,232
Amortized Cost	[1],[2],[12],[18],[23]	1,599,049
Fair Value	[1],[2],[18],[23]	$ 1,250,633
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Envision Healthcare Corp. (First Lien Term Loan) | L + 375 | 4.07 % | 10/10/2025
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[19],[24]			375.00%
Base Rate Floor	[1],[2],[19],[24]			4.07%
Maturity Date	[1],[2],[19],[24]			Oct. 10, 2025
Principal Amount	[1],[2],[19],[24]			$ 4,518,572
Amortized Cost	[1],[2],[12],[19],[24]			3,709,077
Fair Value	[1],[2],[19],[24]			$ 1,354,645
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | RxBenefits Inc. (First Lien Term Loan) | L + 450 | 2.11 % | 12/20/2027
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[19],[20]			450.00%
Base Rate Floor	[1],[2],[19],[20]			2.11%
Maturity Date	[1],[2],[19],[20]			Dec. 20, 2027
Principal Amount	[1],[2],[19],[20]			$ 1,993,177
Amortized Cost	[1],[2],[12],[19],[20]			1,963,107
Fair Value	[1],[2],[19],[20]			$ 1,888,535
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Sound Inpatient Physicians (Second Lien Term Loan) | L + 675 | 4.07 % | 6/26/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[19],[24]			675.00%
Base Rate Floor	[1],[2],[19],[24]			4.07%
Maturity Date	[1],[2],[19],[24]			Jun. 26, 2026
Principal Amount	[1],[2],[19],[24]			$ 1,555,556
Amortized Cost	[1],[2],[12],[19],[24]			1,481,972
Fair Value	[1],[2],[19],[24]			$ 1,229,869
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Sound Inpatient Physicians (Second Lien Term Loan) | SOFR + 675 | 5.64 % | 6/26/2026
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[18],[23]	675.00%
Base Rate Floor	[1],[2],[18],[23]	5.64%
Maturity Date	[1],[2],[18],[23]	Jun. 26, 2026
Principal Amount	[1],[2],[18],[23]	$ 1,555,556
Amortized Cost	[1],[2],[12],[18],[23]	1,500,056
Fair Value	[1],[2],[18],[23]	$ 127,556
Investment, Identifier [Axis]: Senior Secured Loans | Healthcare | Wellpath Holdings Inc. (First Lien Term Loan) | L + 550 | 4.41 % | 10/1/2025
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[19],[22]			550.00%
Base Rate Floor	[1],[2],[19],[22]			4.41%
Maturity Date	[1],[2],[19],[22]			Oct. 01, 2025
Principal Amount	[1],[2],[19],[22]			$ 984,615
Amortized Cost	[1],[2],[12],[19],[22]			980,197
Fair Value	[1],[2],[19],[22]			783,793
Investment, Identifier [Axis]: Senior Secured Loans | Real Estate | NexPoint Capital REIT, LLC (First Lien Term Loan) | PRIME + 100 | 8.00% | 3/25/2025
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[4],[15],[18]	100.00%
Base Rate Floor	[1],[2],[3],[4],[15],[18]	8.00%
Maturity Date	[1],[2],[3],[4],[15],[18]	Mar. 25, 2025
Principal Amount	[1],[2],[3],[4],[15],[18]	$ 463,314
Amortized Cost	[1],[2],[3],[4],[12],[15],[18]	463,314
Fair Value	[1],[2],[3],[4],[15],[18]	463,314
Investment, Identifier [Axis]: Senior Secured Loans | Telecommunication Services
Schedule of Investments [Line Items]
Fair Value	[1],[2]	$ 1,202,629	[18]	$ 1,069,243	[19]
Investment, Identifier [Axis]: Senior Secured Loans | Telecommunication Services | MidWave Wireless, Inc. (fka Terrestar Corp.) (First Lien Term Loan E) | 12% PIK | 12.00% | 2/28/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[4],[18]	12.00%
Base Rate Floor	[1],[2],[3],[4],[18]	12.00%
Maturity Date	[1],[2],[3],[4],[18]	Feb. 28, 2024
Principal Amount	[1],[2],[3],[4],[18]	$ 915,322
Amortized Cost	[1],[2],[3],[4],[12],[18]	915,322
Fair Value	[1],[2],[3],[4],[18]	$ 912,118
Investment, Identifier [Axis]: Senior Secured Loans | Telecommunication Services | MidWave Wireless, Inc. (fka Terrestar Corp.) (First Lien Term Loan F) | 12% PIK | 12.00% | 2/28/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[4],[18]	12.00%
Base Rate Floor	[1],[2],[3],[4],[18]	12.00%
Maturity Date	[1],[2],[3],[4],[18]	Feb. 28, 2024
Principal Amount	[1],[2],[3],[4],[18]	$ 216,696
Amortized Cost	[1],[2],[3],[4],[12],[18]	216,696
Fair Value	[1],[2],[3],[4],[18]	$ 215,938
Investment, Identifier [Axis]: Senior Secured Loans | Telecommunication Services | MidWave Wireless, Inc. (fka Terrestar Corp.) (First Lien Term Loan G) | 12% PIK | 12.00% | 2/28/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[4],[18]	12.00%
Base Rate Floor	[1],[2],[3],[4],[18]	12.00%
Maturity Date	[1],[2],[3],[4],[18]	Feb. 28, 2024
Principal Amount	[1],[2],[3],[4],[18]	$ 38,714
Amortized Cost	[1],[2],[3],[4],[12],[18]	38,714
Fair Value	[1],[2],[3],[4],[18]	$ 38,579
Investment, Identifier [Axis]: Senior Secured Loans | Telecommunication Services | MidWave Wireless, Inc. (fka Terrestar Corp.) (First Lien Term Loan H) | 12% PIK | 12.00% | 2/28/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[4],[18]	12.00%
Base Rate Floor	[1],[2],[3],[4],[18]	12.00%
Maturity Date	[1],[2],[3],[4],[18]	Feb. 28, 2024
Principal Amount	[1],[2],[3],[4],[18]	$ 36,121
Amortized Cost	[1],[2],[3],[4],[12],[18]	36,121
Fair Value	[1],[2],[3],[4],[18]	35,994
Investment, Identifier [Axis]: Senior Secured Loans | Telecommunication Services | Terrestar Corp. (First Lien Term Loan E) | 11% PIK | 2/28/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[9],[19]			11.00%
Maturity Date	[1],[2],[3],[9],[19]			Feb. 28, 2024
Principal Amount	[1],[2],[3],[9],[19]			$ 815,685
Amortized Cost	[1],[2],[3],[9],[12],[19]			815,684
Fair Value	[1],[2],[3],[9],[19]			$ 810,953
Investment, Identifier [Axis]: Senior Secured Loans | Telecommunication Services | Terrestar Corp. (First Lien Term Loan F) | 11% PIK | 2/28/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[9],[19]			11.00%
Maturity Date	[1],[2],[3],[9],[19]			Feb. 28, 2024
Principal Amount	[1],[2],[3],[9],[19]			$ 193,108
Amortized Cost	[1],[2],[3],[9],[12],[19]			193,108
Fair Value	[1],[2],[3],[9],[19]			$ 191,988
Investment, Identifier [Axis]: Senior Secured Loans | Telecommunication Services | Terrestar Corp. (First Lien Term Loan G) | 11% PIK | 2/28/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[9],[19]			11.00%
Maturity Date	[1],[2],[3],[9],[19]			Feb. 28, 2024
Principal Amount	[1],[2],[3],[9],[19]			$ 34,500
Amortized Cost	[1],[2],[3],[9],[12],[19]			34,500
Fair Value	[1],[2],[3],[9],[19]			$ 34,300
Investment, Identifier [Axis]: Senior Secured Loans | Telecommunication Services | Terrestar Corp. (First Lien Term Loan H) | 11% PIK | 2/28/2024
Schedule of Investments [Line Items]
Interest Rate	[1],[2],[3],[9],[19]			11.00%
Maturity Date	[1],[2],[3],[9],[19]			Feb. 28, 2024
Principal Amount	[1],[2],[3],[9],[19]			$ 32,189
Amortized Cost	[1],[2],[3],[9],[12],[19]			32,189
Fair Value	[1],[2],[3],[9],[19]			32,002
Investment, Identifier [Axis]: Total Investments | Cash Equivalents
Schedule of Investments [Line Items]
Fair Value	[1],[2],[25]	1,160,707		1,420,428
Investment, Identifier [Axis]: Total Investments | Other Assets & Liabilities net
Schedule of Investments [Line Items]
Fair Value	[1],[2]	(764,467)		(1,019,976)
Investment, Identifier [Axis]: Warrants
Schedule of Investments [Line Items]
Fair Value	[1],[2]	272,969		181,733
Investment, Identifier [Axis]: Warrants | Energy
Schedule of Investments [Line Items]
Fair Value	[1],[2]	266,500		$ 161,249
Investment, Identifier [Axis]: Warrants | Energy | QuarterNorth Tranche 1
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[14]	5,738
Amortized Cost	[1],[2],[12],[14]	16,122
Fair Value	[1],[2],[14]	133,888
Investment, Identifier [Axis]: Warrants | Energy | QuarterNorth Tranche 1 | 8/27/2029
Schedule of Investments [Line Items]
Maturity Date	[1],[2],[14]			Aug. 27, 2029
Principal Amount	[1],[2],[14]			$ 5,738
Amortized Cost	[1],[2],[12],[14]			16,122
Fair Value	[1],[2],[14]			$ 64,553
Investment, Identifier [Axis]: Warrants | Energy | QuarterNorth Tranche 2
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[14]	11,051
Amortized Cost	[1],[2],[12],[14]	5,175
Fair Value	[1],[2],[14]	132,612
Investment, Identifier [Axis]: Warrants | Energy | QuarterNorth Tranche 2 | 8/27/2029
Schedule of Investments [Line Items]
Maturity Date	[1],[2],[14]			Aug. 27, 2029
Principal Amount	[1],[2],[14]			$ 11,051
Amortized Cost	[1],[2],[12],[14]			5,175
Fair Value	[1],[2],[14]			$ 96,696
Investment, Identifier [Axis]: Warrants | Media/Telecommunications | iHeartMedia Inc.
Schedule of Investments [Line Items]
Principal Amount	[1],[2],[8],[14]	2,875
Amortized Cost	[1],[2],[8],[12],[14]	52,987
Fair Value	[1],[2],[8],[14]	6,469
Investment, Identifier [Axis]: Warrants | Media/Telecommunications | iHeartMedia Inc. | 5/1/2039
Schedule of Investments [Line Items]
Maturity Date	[1],[2],[11],[14]			May 01, 2039
Principal Amount	[1],[2],[11],[14]			$ 2,875
Amortized Cost	[1],[2],[11],[12],[14]			52,987
Fair Value	[1],[2],[11],[14]			20,484
Investment, Identifier [Axis]: Warrants | Total Investments
Schedule of Investments [Line Items]
Amortized Cost	[1],[2],[12]	45,998,823		54,011,971
Fair Value	[1],[2]	$ 49,413,286		$ 53,293,715

[1] All investments are denominated in United States Dollars.

[2] Unless otherwise noted, the Company did not “control” and was not an “affiliated person” of any of its portfolio companies, each as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). In general, under the 1940 Act, the Company would be presumed to “control” a portfolio company if it owned 25% or more of its voting securities or had the power to exercise control over the management or policies of such portfolio company, and would be an “affiliated person” of a portfolio company if it owned 5% or more of its voting securities. Additionally, companies under common control (e.g., companies with a common owner of greater than 25% of their respective voting securities) are affiliates under the 1940 Act.

[3] Classified as Level 3 within the three-tier fair value hierarchy. Please see Note 2 for an explanation of this hierarchy, as well as a list of unobservable inputs used in the valuation of these instruments.

[4] Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Directors (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $38,516,582 or 77.3% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2023.

[5] Securities exempt from registration under Rule 144A of the Securities Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of December 31, 2023, these securities amounted to $84, or 0.0% of net assets.

[6] Securities of collateralized loan obligations where an affiliate of the Adviser serves as collateral manager.

[7] The investment is considered to be the equity tranche of the issuer.

[8] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2023.

[9] Represents fair value as determined by the Adviser pursuant to the policies and procedures approved by the Board of Directors (the “Board”). The Board has designated the Adviser as “valuation designee” for the Company pursuant to Rule 2a-5 of the 1940 Act. The Adviser considers fair valued securities to be securities for which market quotations are not readily available and these securities may be valued using a combination of observable and unobservable inputs. Securities with a total aggregate value of $28,500,789 or 53.0% of net assets were fair valued under the Company’s valuation procedures as of December 31, 2022.

[10] Securities exempt from registration under Rule 144A of the Securities Act. These securities may only be resold in transactions exempt from registration to qualified institutional buyers. As of December 31, 2022, these securities amounted to $2,421,875, or 4.5% of net assets.

[11] The investment is not a qualifying asset under Section 55 of the 1940 Act. A business development company, such as the Company (“BDC”), may not acquire any asset other than a qualifying asset, unless at the time the acquisition is made, qualifying assets represent at least 70% of the business development company’s total assets. Non-qualifying assets represented 4.8% of the Company’s total assets as of December 31, 2022.

[12] Amortized cost represents the original cost adjusted for the amortization of premiums and/or accretion of discounts, as applicable, on investments.

[13] The issuer is in default of its payment obligation, or is in danger of default.

[14] Non-income producing security.

[15] Represents an affiliated issuer. Assets with a total aggregate market value of $10,696,845, or 21.5% of net assets, were affiliated with the Company as of December 31, 2023. See Note 9.

[16] Represents an affiliated issuer. Assets with a total aggregate market value of $10,273,001, or 19.1% of net assets, were affiliated with the Company as of December 31, 2022. See Note 10.

[17] All or a portion of this security is held through BDC Sapience Holdco, LLC (See Note 1)

[18] Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by the Federal Reserve Bank such as the Secured Overnight Financing Rate (“SOFR”) or (iii) the coupon rate. Rate shown represents the actual rate at December 31, 2023. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown.

[19] Senior secured loans in which the Company invests generally pay interest at rates which are periodically determined by reference to a base lending rate plus a spread (unless otherwise identified, all senior secured loans carry a variable rate of interest). These base lending rates are generally (i) the Prime Rate offered by one or more major United States banks, (ii) the lending rate offered by one or more European banks such as the London Interbank Offered Rate (“LIBOR”) or (iii) the coupon rate. Rate shown represents the actual rate at December 31, 2022. Senior secured loans, while exempt from registration under the Securities Act of 1933 (the “1933 Act”), contain certain restrictions on resale and cannot be sold publicly. Senior secured floating rate loans often require prepayments from excess cash flow or permit the borrower to repay at its election. The degree to which borrowers repay, whether as a contractual requirement or at their election, cannot be predicted with accuracy. As a result, the actual remaining maturity may be substantially less than the stated maturity shown.

[20] The interest rate on these investments is subject to a base rate of 6-Month LIBOR, which at December 31, 2022 was 5.14%. The LIBOR rate used to calculate interest is the higher of the prevailing 6 month LIBOR rate in effect on the date of the semiannual reset, or the LIBOR base rate floor shown.

[21] The interest rate on these investments is subject to a base rate of 6-Month SOFR which at December 31, 2023 was 5.16%. The SOFR rate used to calculate interest is the higher of the prevailing 6 month SOFR rate in effect on the date of the semiannual reset, or the SOFR base rate floor shown.

[22] The interest rate on these investments is subject to a base rate of 3-Month LIBOR, which at December 31, 2022 was 4.77%. The LIBOR rate used to calculate interest is the higher of the prevailing 3 month LIBOR rate in effect on the date of the quarterly reset, or the LIBOR base rate floor shown.

[23] The interest rate on these investments is subject to a base rate of 3-Month SOFR, which at December 31, 2023 was 5.33%

[24] The interest rate on these investments is subject to a base rate of 1-Month LIBOR, which at December 31, 2022 was 4.39%. The LIBOR rate used to calculate interest is the higher of the prevailing 1 month LIBOR rate in effect on the date of the monthly reset, or the LIBOR base rate floor shown.

[25] State Street U.S. Government Money Market Fund.